H.B. Fuller (NYSE:FUL) Stock Rating Lowered by Seaport Res Ptn

H.B. Fuller (NYSE:FUL) was downgraded by equities researchers at Seaport Res Ptn from a “strong-buy” rating to a “hold” rating in a report released on Wednesday,Zacks.com reports. Seaport Res Ptn also issued estimates for H.B. Fuller’s Q1 2025 earnings at $0.43 EPS, Q2 2025 earnings at $0.99 EPS and FY2025 earnings at $3.70 EPS.

A number of other research analysts also recently issued reports on FUL. Deutsche Bank Aktiengesellschaft reduced their price target on shares of H.B. Fuller from $75.00 to $72.00 and set a “buy” rating on the stock in a research report on Wednesday, January 22nd. Vertical Research downgraded shares of H.B. Fuller from a “buy” rating to a “hold” rating in a research report on Monday, January 6th. Citigroup reduced their price target on shares of H.B. Fuller from $78.00 to $68.00 and set a “neutral” rating on the stock in a research report on Friday, January 3rd. Finally, JPMorgan Chase & Co. reduced their price target on shares of H.B. Fuller from $70.00 to $60.00 and set an “underweight” rating on the stock in a research report on Friday, January 17th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and one has issued a buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Hold” and an average target price of $75.60.

H.B. Fuller Price Performance

Shares of FUL stock opened at $57.08 on Wednesday. The firm has a market cap of $3.12 billion, a P/E ratio of 24.71, a P/E/G ratio of 1.13 and a beta of 1.41. The company has a debt-to-equity ratio of 1.10, a current ratio of 1.81 and a quick ratio of 1.16. H.B. Fuller has a 1-year low of $54.18 and a 1-year high of $87.67. The firm has a fifty day moving average of $61.53 and a two-hundred day moving average of $71.93.

H.B. Fuller (NYSE:FUL) last announced its quarterly earnings data on Wednesday, January 15th. The specialty chemicals company reported $0.92 earnings per share for the quarter, missing the consensus estimate of $1.00 by ($0.08). H.B. Fuller had a return on equity of 12.01% and a net margin of 3.65%. The company had revenue of $923.00 million for the quarter, compared to analyst estimates of $916.84 million. During the same period in the prior year, the business earned $1.32 earnings per share. H.B. Fuller’s revenue was up 2.2% on a year-over-year basis. As a group, research analysts anticipate that H.B. Fuller will post 4.07 earnings per share for the current fiscal year.

Institutional Trading of H.B. Fuller

Several hedge funds have recently bought and sold shares of FUL. S&CO Inc. raised its position in shares of H.B. Fuller by 0.3% during the 3rd quarter. S&CO Inc. now owns 267,192 shares of the specialty chemicals company’s stock worth $21,209,000 after buying an additional 920 shares in the last quarter. Geode Capital Management LLC raised its position in shares of H.B. Fuller by 1.5% during the 3rd quarter. Geode Capital Management LLC now owns 1,258,752 shares of the specialty chemicals company’s stock worth $99,939,000 after buying an additional 18,734 shares in the last quarter. Lord Abbett & CO. LLC raised its position in shares of H.B. Fuller by 79.8% during the 3rd quarter. Lord Abbett & CO. LLC now owns 730,058 shares of the specialty chemicals company’s stock worth $57,952,000 after buying an additional 324,056 shares in the last quarter. Wesbanco Bank Inc. raised its position in shares of H.B. Fuller by 41.2% during the 4th quarter. Wesbanco Bank Inc. now owns 13,700 shares of the specialty chemicals company’s stock worth $924,000 after buying an additional 4,000 shares in the last quarter. Finally, Bank of New York Mellon Corp raised its position in shares of H.B. Fuller by 17.2% during the 4th quarter. Bank of New York Mellon Corp now owns 554,947 shares of the specialty chemicals company’s stock worth $37,448,000 after buying an additional 81,558 shares in the last quarter. 95.93% of the stock is currently owned by institutional investors.

About H.B. Fuller

H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives.